Quantcast

Promescent® Featured in World Meeting on Sexual Medicine 2012

August 3, 2012

Excitement for Promescent as the leading solution for premature ejaculation continues to build, with more than 200 physicians now recommending the product.

Huntington Beach, CA (PRWEB) August 03, 2012

Considered by many physicians of sexual medicine as the leading solution for premature ejaculation, Absorption Pharmaceuticals’ Promescent will be featured at the SMSNA/ISSM conference in Chicago, August 26-30. Initially introduced at the SMSNA conference in Las Vegas in November 2011, Promescent continues to gain momentum in both the medical community and with men and women in the general public wishing to increase sexual satisfaction.

“Because of its effectiveness, we quickly established Promescent as the product of choice for PE by key opinion leaders of sexual medicine,” says Jeff Abraham, Absorption’s CEO. “We expect a lot of interest from a variety of physicians at the upcoming SMSNA/ISSM conference.”

There are now over 200 physicians recommending Promescent to their patients who desire to extend their ejaculatory response time. Feedback from these patients and doctors has been overwhelmingly positive. The awareness of this premier PE treatment and its proprietary technology has been further highlighted with recent media coverage that has resulted in a significant consumer response for additional information and product samples. Absorption recently increased its sales team and is currently ramping up its FDA-compliant manufacturing capacity in order to meet product demand.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpremature_ejaculation/sexual_medicine/prweb9764370.htm


Source: prweb



comments powered by Disqus